Pharmaceutical equivalence of oncology products marketed in Brazil

Pharmaceutical equivalence of oncology products marketed in Brazil

Show other versions (1)

The aim of this work was to assess pharmaceutical equivalence among medicinal products containing cisplatin, doxorubicin hydrochloride and paclitaxel that are marketed in Brazil by various manufacturers. We analyzed 14 lots of cisplatin injectable solution from 4 manufacturers (Labs B, C, H and I),...

Full description

Bibliographic Details
Main Authors: Marcus Augusto Lyrio Traple, Rosa Noriko Yamamoto, Daniela Dal Molin Ghisleni, Rogério Takao Okamoto, Elisabete Almeida Barbosa, Terezinha de Jesus Andreoli Pinto, Felipe Rebello Lourenço
Format: Article
Language:English
Published: São Paulo State University (UNESP) 2013-10-01
Series:Revista de Ciências Farmacêuticas Básica e Aplicada
Subjects:
therapeutic equivalence. medical oncology. cisplatin. doxorubicin. paclitaxel
Online Access:http://rcfba.fcfar.unesp.br/index.php/ojs/article/view/171

Internet

http://rcfba.fcfar.unesp.br/index.php/ojs/article/view/171

Similar Items